-
EP2046836
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2046836
| EP2046836 - ANTIBODY SPECIFICALLY BINDING TO DR5 AND COMPOSITION FOR PREVENTING OR TREATING CANCERS COMPRISING THE SAME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.04.2013 Database last updated on 27.07.2024 | Most recent event Tooltip | 26.04.2013 | Application deemed to be withdrawn | published on 29.05.2013 [2013/22] | Applicant(s) | For all designated states Ajou University Industry-Academic Cooperation Foundation San 5, Woncheon-dong Youngtong-gu Suwon-si, Gyeonggi-do 443-749 / KR | [2009/16] | Inventor(s) | 01 /
KIM, Yong Sung Hyundai Hometown 112-302 76, Maetan-dong Youngtong-gu Suwon-si, Gyeonggi-do 443-370 / KR | 02 /
KWON, Myung Hee Campusville 809, 37-17 Woncheon-dong Youngtong-gu Suwon-si, Gyeonggi-do 443-821 / KR | 03 /
LEE, Seung Hyun Geojang 2-cha Apt. 105-407, Seogok-ri Panbu-myeon Wonju-si, Gangwon-do 220-750 / KR | 04 /
PARK, Kyung Jin 70-25, Hwaseo-dong Paldal-gu Suwon-si, Gyeonggi-do 442-150 / KR | 05 /
LEE, Hae Won Toegyejugong Apt. 7-danji 706-401, Toegye-dong Chuncheon-si, Gangwon-do 200-170 / KR | [2009/16] | Representative(s) | Goddar, Heinz J. Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München / DE | [N/P] |
| Former [2009/16] | Goddar, Heinz J. Forrester & Boehmert Pettenkoferstrasse 20-22 80336 München / DE | Application number, filing date | 07746791.8 | 31.05.2007 | [2009/16] | WO2007KR02644 | Priority number, date | KR20060063126 | 05.07.2006 Original published format: KR 20060063126 | KR20070038937 | 20.04.2007 Original published format: KR 20070038937 | [2009/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008004760 | Date: | 10.01.2008 | Language: | EN | [2008/02] | Type: | A1 Application with search report | No.: | EP2046836 | Date: | 15.04.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application. | [2009/16] | Search report(s) | International search report - published on: | KR | 10.01.2008 | (Supplementary) European search report - dispatched on: | EP | 24.10.2012 | Classification | IPC: | C07K16/28, A61K39/00, A61P35/00 | [2009/16] | CPC: |
C07K16/2878 (EP,US);
C07K16/28 (KR);
A61P35/00 (EP);
A61P43/00 (EP);
C07K16/00 (KR);
A61K2039/505 (EP,US);
C07K2317/34 (EP,US);
C07K2317/56 (EP,US);
C07K2317/565 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/16] | Title | German: | SPEZIFISCH AN DR5 BINDENDER ANTIKÖRPER UND ZUSAMMENSETZUNG ZUR PRÄVENTION ODER BEHANDLUNG VON KREBS, DIE DIESEN ENTHÄLT | [2009/16] | English: | ANTIBODY SPECIFICALLY BINDING TO DR5 AND COMPOSITION FOR PREVENTING OR TREATING CANCERS COMPRISING THE SAME | [2009/16] | French: | ANTICORPS SE LIANT SPÉCIFIQUEMENT À DR5 ET COMPOSITION DESTINÉE À PRÉVENIR OU TRAITER DES CANCERS ET COMPRENANT CET ANTICORPS | [2009/16] | Entry into regional phase | 30.01.2009 | National basic fee paid | 30.01.2009 | Search fee paid | 30.01.2009 | Designation fee(s) paid | 30.01.2009 | Examination fee paid | Examination procedure | 30.01.2009 | Amendment by applicant (claims and/or description) | 30.01.2009 | Examination requested [2009/16] | 01.12.2012 | Application deemed to be withdrawn, date of legal effect [2013/22] | 11.01.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/22] | Fees paid | Renewal fee | 28.05.2009 | Renewal fee patent year 03 | 31.03.2010 | Renewal fee patent year 04 | 11.05.2011 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.05.2012 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]EP1396500 (KIRIN BREWERY [JP]) [I] 1-21* the whole document *; | [I]WO2005056605 (CHUGAI PHARMACEUTICAL CO LTD [JP], et al) [I] 1-21 * the whole document *; | [IP]EP1710255 (CHUGAI PHARMACEUTICAL CO LTD [JP]) [IP] 1-21 | International search | [A]US2003190687 (ZHOU TONG [AL], et al); | [X] - PARK K.-J. ET AL., "A novel anti-DR5 human scFv antibodies induce cell death in multiple tumors in monomeric form", THE KOREAN SOCIETY FOR MICROBIOLOGY AND BIOTECHNOLOGY, (20060620), vol. J-13 | [X] - LEE H.-W. ET AL., "Construction and characterization of a pseudo-immune human antibody library using yeast surface display", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (20060609), vol. 346, pages 896 - 903, XP024925400 DOI: http://dx.doi.org/10.1016/j.bbrc.2006.05.202 | [A] - YAGITA H. ET AL., "TRAIL and its receptors as targets for cancer therapy", CANCER SCIENCE, (200410), vol. 96, no. 10, pages 777 - 783, XP008102256 DOI: http://dx.doi.org/10.1111/j.1349-7006.2004.tb02181.x | [A] - ICHIKAWA K. ET AL., "Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity", NATURE MEDICINE, (200108), vol. 7, no. 8, pages 954 - 960, XP002484674 DOI: http://dx.doi.org/10.1038/91000 | [A] - OHTSUKA T. ET AL., "Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway", ONCOGENE, (20030403), vol. 22, no. 13, pages 2034 - 2044, XP002446171 DOI: http://dx.doi.org/10.1038/sj.onc.1206290 |